Imprensa e descargas
As informações contidas nestas páginas destinam-se exclusivamente aos representantes dos meios de comunicação social e aos investidores.
Contacto:
Michael Donhofer
Director Global Marketing & Public Relations
Mobile: +43 676 84 68 68 823
E-mail: michael.donhofer@croma.at
Croma-Pharma announces partnership with Megalabs
Croma-Pharma announces partnership with Megalabs, bringing high-performance aesthetic products to…
Further clinical data confirms the safety and efficacy of letibotulinumtoxinA
Croma-Pharma has announced the publication of further clinical data for…
Letybo® receives FDA Approval for the treatment of glabellar lines
Croma-Pharma announced today that Hugel, Korean toxin manufacturer and partner…
